High Tide Inc.
HITI • Medical - Pharmaceuticals
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jan 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$208.25M
Growth
50.4%
Cash Flow
3/5
Trend
Mostly stable
Evidence
Positive revenue growth · 14.1%Positive free cash flow · 0.16Healthy liquidity · 1.37Weak profitability
Financial data as of: Jan 31, 2026, 12:00 AM UTCLast earnings update: Mar 17, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change0.00%
Market Cap$208.25M
52W Range2.12 - 4.05
Beta0.57
Gross Margin25.85%
Oper. Margin-2.43%
Profit Margin-8.54%
Debt/Eq1.71
Current Ratio1.37
Quick Ratio0.70
Revenue 5Y50.35%
Price$0.00
Change0.00%
Market Cap$208.25M
52W Range2.12 - 4.05
Beta0.57
Gross Margin25.85%
Oper. Margin-2.43%
Profit Margin-8.54%
Debt/Eq1.71
Current Ratio1.37
Quick Ratio0.70
Revenue 5Y50.35%
FCF 5Y43.24%
Target$2.70
Target Median$2.70
Target Range2.70 - 2.70
Volume1.41M
Avg Volume607.06K
EPS Surprise0.03
Investment DNA
How strong this company looks for long-term investors
46
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
39/100
Growth Potential
Revenue and expansion
58/100
Price Attractiveness
Cheap or expensive today
74/100
Why this score▼
Positive revenue growth · 14.1%Positive free cash flow · 0.16Healthy liquidity · 1.37Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-06-18
Low
$2.70
Mean
$2.70
Median
$2.70
High
$2.70
🧾
No insider activity
No recent insider transactions available.